🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In 2007-2009 the investigators conducted a study to determine the immunogen...
Status
Terminated
Location
Royal Childrens Hospital
Start Date
2012-03
Trial ID
NCT01896986
This retrospective study aims to assess the effectiveness of systemic treat...
Status
Completed
Location
Erasmus MC
Start Date
2022-09-23
Trial ID
NCT06512766
Treatments Being Tested
This project involved a systematic literature review of published trials of...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT01425138
Study to evaluate the efficacy of treatment by radiotherapy and pembrolizum...
Status
Recruiting
Location
Institut Sainte Catherine
Start Date
2021-12-01
Trial ID
NCT04747054
Treatments Being Tested
This is an open-label randomized phase II study. Patients are randomized so...
Status
Withdrawn
Location
University of California
Start Date
2015-06
Trial ID
NCT01530984
Treatments Being Tested
Observational investigation of participants who are given neoadjuvant treat...
Status
Not Yet Recruiting
Location
National Institute of Oncolgy
Start Date
2022-03
Trial ID
NCT05131893
The goal of this clinical trial is to investigate the immunomodulatory effe...
Status
Recruiting
Location
Intensive Care Medicine, Radboud University Nijmegen Medical Centre
Start Date
2024-10-24
Trial ID
NCT06624436
Treatments Being Tested
The objectives of this prospective non-interventional study are to characte...
Status
Recruiting
Location
Cahaba Dermatology & Skin Health Center- Site Number : 8400006
Start Date
2025-11-17
Trial ID
NCT07290803
This study is to collect and validate regulatory-grade real-world data (RWD...
Status
Completed
Location
Teton Cancer Institute
Start Date
2021-05-05
Trial ID
NCT04028479
Treatments Being Tested
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer...
Status
Not Yet Recruiting
Location
London Health Sciences Center
Start Date
2026-02
Trial ID
NCT07292142
Treatments Being Tested